Filter posts

Emerging Company Policy Deconstructed: Small Cap Liquidity Reform Act (H.R. 3448)

In a nutshell: This bill, sponsored by Reps. Sean Duffy (R-WI) and John Carney (D-DE), …

Emerging Company Policy Deconstructed: Start-up Jobs and Innovation Act (S. 1658)

In a nutshell: Senators Robert Menendez (D-NJ) and Pat Toomey (R-PA) introduced the Start-up Jobs …

BIO Investor Forum Company Snapshot: AM-Pharma

The BIO Investor Forum will be taking place this October in San Francisco for its …

Biotech Hall of Fame: Interview with Biotech’s First Investment Banker

Earlier this week, I had the opportunity to discuss biotech’s storied history with Fred Frank, …

The Year Ahead for Business Development Events

2013 is officially here (insert stale End-of-the-World joke). And as such, planning has been in …

Data Exclusivity Protects Innovators and Assures Investors

Biotechnology companies must have some certainty that they can protect their investment in the development …

It Takes a Village: The New Pharma-VC Model for Biotech Investing

High-profile funding collaborations between pharmaceutical companies and traditional venture capital funds have made headlines in …

BIO Investor Forum: The New Kids on the Biotech Block

Where should biotech start-ups look for funding in the venture capital desert that is becoming …

BIO Technology Transfer Symposium: Funding that First $2 Million

With creative funding schemes picking up steam and nontraditional funders taking an interest in biotech, …

Picks and Pans – The Buy-Side View for 2012

What’s the forecast for biotech in 2012? Do investors think it is a good time …